PEABODY ENERGY CORP financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data PEABODY ENERGY CORP files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2015	FY2016	FY2019	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	5,609	4,715	5,582	4,623	2,881	3,318	4,982	4,947	4,237	3,862
Selling, general and administrative	176	153	158	145	99.5	84.9	88.8	90.7	91	105
Operating income	-1,465	-277	662	61.7	-1,728	432	1,382	1,075	445	-80.1
Interest expense	465	299	151	144	140	183	140	59.8	46.9	43.9
Interest income	7.7	5.7	33.6	27	9.4	6.5	18.4	76.8	71	55.4
Pre-tax income	-1,990	-758	664	-142	-1,852	370	1,279	1,125	516	-33.5
Income tax	-207	-94.5	18.4	46	8	22.8	-38.8	309	109	8.8
Income from continuing operations	-1,790	-672	526	-215	-1,856	336	1,295	760	375	-52.7
Net income to minority interests	7.1	7.9	16.9	26.2	-3.5	11.3	22	56	32.6	10.4
Net income	-1,965	-729	544	-211	-1,870	360	1,297	760	371	-52.9
EBITDA	-893	189	1,341	663	-1,382	741	1,699	1,396	788	304
EPS, basic	-108.29	-39.87	4.50	-2.04	-19.14	3.24	9.13	5.52	2.96	-0.43
EPS, diluted	-108.29	-39.87	4.43	-2.04	-19.14	3.22	8.31	5.00	2.70	-0.43
Shares, basic (weighted)	18.1	18.3	119	104	97.7	111	142	138	125	122
Shares, diluted (weighted)	18.1	18.3	2.1	104	97.7	112	157	154	142	122
Dividend per share	0.08	0.00	0.49	2.41				0.23	0.23	0.30

Balance sheet

	FY2015	FY2016	FY2019	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash and equivalents	261	872	1,017	732	709	954	1,307	969	700	575
Receivables	229	473	450	330	245	351	466	390	359	315
Inventory	308	204	280	332	262	227	296	352	393	383
Other current assets	448	487	243	221	205	270	304	309	328	285
Total current assets	1,323	2,091	1,956	1,614	1,420	1,802	2,373	2,020	1,781	1,559
Property, plant and equipment	9,259	8,777	5,207	4,679	3,051	2,951	2,865	2,844	3,082	3,153
Lease right-of-use assets			0	82.4	49.9	35.5	26.9	61.9	119	121
Intangible assets				40.7
Other non-current assets	364	910	213	139	141	138	84.3	78.8	162	128
Total assets	10,947	11,778	7,424	6,543	4,667	4,950	5,611	5,962	5,954	5,807
Accounts payable	333	289	282	255	146	202	241	276	228	205
Accrued liabilities	192	201	209	186	164	171	199	174	177	188
Short-term debt	5,875	20.2	36.5	18.3	44.9	59.6	13.2	13.5	15.8	15.2
Total current liabilities	7,337	1,012	1,059	975	791	932	919	979	828	842
Long-term debt	366	0	1,331	1,293	1,503	1,078	321	321	332	321
Lease liabilities			0	52.8	42.1	27.2	11	47.7	86.7	87.5
Other non-current liabilities	847	496	339	273	252	198	223	182	169	146
Total liabilities	10,195	11,596	3,972	3,870	3,686	3,129	2,316	2,355	2,245	2,225
Total debt	6,241	20.2	1,367	1,311	1,548	1,138	334	334	348	336
Paid-in capital	2,411	2,422	3,305	3,351	3,365	3,746	3,976	3,983	3,991	4,005
Retained earnings	670	1,400	1,075	597	-1,273	-913	384	1,113	1,446	1,356
Treasury stock	-372	-372	-1,025	-1,367	-1,369	-1,370	-1,373	-1,740	-1,927	-1,927
Other comprehensive income	-619	-477	40.1	31.6	206	298	243	190	139	101
Shareholders' equity	750	174	3,396	2,614	930	1,762	3,231	3,547	3,651	3,536
Minority interests	1.6	7.6	56	58.7	51.7	59	63.5	60.5	58.3	45.8
Total equity	752	182	3,452	2,673	981	1,821	3,295	3,608	3,709	3,582
Total liabilities and equity	10,947	11,778	7,424	6,543	4,667	4,950	5,611	5,962	5,954	5,807
Shares outstanding	18.5	18.5	110	96.9	97.8	133	144	129

Cash flow statement

	FY2015	FY2016	FY2019	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Net income	-1,958	-721	664	-185	-1,874	371	1,319	816	404	-42.5
Depreciation and amortization	572	465	679	601	346	309	318	321	343	385
Stock-based compensation	26.2		34.9	38.3	13.5	10	8.4	6.9	7.3	13.8
Deferred income tax	-138	-97	35.5	39.4	27.8	-7.5	-81.6	82.9	12.2	-16.7
Change in receivables	188	-101	172	82.9	84.6	-106	-115	88.4	21.9	48.8
Change in inventory	96.2	104	50.2	-53.3	69.9	35	-69.4	-59.7	-41.6	10.2
Change in payables	-382	157	-160	-118	-192	128	68	120	-185	10.3
Cash from operations	-14.4	-52.8	1,490	677	-9.7	420	1,174	1,036	607	334
Capital expenditures	-127	-127	-301	-285	-191	-183	-222	-348	-401	-411
Acquisitions			-387	-2.4	0	0
Purchases of investments	-28.8	0	-10	-3	0	0
Sales and maturities of investments	90.3	0
Cash from investing	-290	-244	-517	-261	-207	-132	-28.7	-343	-598	-347
Debt issued	976	1,458	0	0	375	0	545	0	0
Stock issued	3.4	0	0	0	0	270	222	0	0
Share buybacks			-835	-330	0	0	0	-348	-183	0
Dividends paid	-1.4	0	-59.6	-258	0	0	0	-30.6	-37.6	-36.5
Cash from financing	268	908	-1,025	-701	193	-43.4	-682	-460	-276	-85.2
Net change in cash	-36.7	611	-52.8	-285	-23	245	463	233	-268	-98.1
Free cash flow	-141	-179	1,189	392	-201	237	952	687	205	-77.7
Interest paid	414	132
Income taxes paid	-25.8	-40.1	-64	-9.1	-39.9	11.6	36.6	131	223	26

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $25.44 on September 25, 2026.

Profitability

Metric	Value	How it is calculated
Operating margin	-5.6%	Operating income / revenue.
EBITDA margin	4.8%	EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin	-5.3%	Pre-tax income / revenue.
Net margin	-4.6%	Net income / revenue.
Operating cash flow margin	5.5%	Cash from operations / revenue.
Return on equity (ROE)	-5.6%	Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)	-3.4%	Net income / average total assets.
Return on invested capital (ROIC)	-5.8%	Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
SG&A / revenue	2.8%	Selling, general and administrative expense / revenue.
Stock-based pay / revenue	0.4%	Stock-based compensation (from the cash flow statement) / revenue.
D&A / revenue	10.4%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	-8.9%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	-8.1%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	6.0%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y	-118.0%	Operating income vs the same period a year earlier. Only from a positive base.
EBITDA growth, 1y	-61.4%	EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y	-43.6%	Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Net income growth, 1y	-114.3%	Net income vs the same period a year earlier. Only from a positive base.
EPS growth, 1y	-115.9%	EPS vs the same period a year earlier. Only from a positive base.
Operating cash flow growth, 1y	-45.0%	Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y	-34.2%	Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Free cash flow growth, 1y	-137.9%	Free cash flow vs the same period a year earlier. Only from a positive base.
Dividend per share growth, 1y	33.3%	Dividend per share vs the same period a year earlier. Only from a positive base.
Book value growth, 1y	-3.1%	Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y	3.1%	Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y	30.6%	Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y	-2.5%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	1.2%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	4.5%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	-14.2%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	-8.2%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	4.5%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	2.01x	Current assets / current liabilities.
Quick ratio	1.06x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	0.65x	(Cash + short-term investments) / current liabilities.
Debt / equity	0.10x	Total debt / shareholders' equity. Not shown when equity is negative.
Debt / assets	6.2%	Total debt / total assets.
Liabilities / assets	39.5%	Total liabilities / total assets.
Net debt	-$187.3M	Total debt - cash - short-term investments. Negative means more cash than debt.
Net debt / EBITDA	-0.97x	Net debt / EBITDA (twelve months), when EBITDA is positive.
Interest coverage	-4.99x	Operating income / interest expense.
Working capital	$813.4M	Current assets - current liabilities.
Tangible book value	$3.25B	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	0.74x	Revenue / average total assets.
Fixed asset turnover	1.30x	Revenue / average property, plant and equipment.
Receivables turnover	12.2x	Revenue / average receivables.
Days sales outstanding	30 days	365 x average receivables / revenue.

Per share

Metric	Value	How it is calculated
EPS, diluted	-$1.50	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share	$32.88	Revenue / diluted weighted shares.
Operating cash flow per share	$1.80	Cash from operations / diluted weighted shares.
Book value per share	$26.63	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	$26.63	Tangible book value / shares outstanding.
Cash per share	$4.31	(Cash + short-term investments) / shares outstanding.

Valuation

Metric	Value	How it is calculated
Market cap	$3.10B	Share price x shares outstanding.
Enterprise value	$2.91B	Market cap + total debt - cash - short-term investments.
P/S	0.77x	Market cap / revenue.
P/B	0.95x	Market cap / shareholders' equity. Only when equity is positive.
Price / tangible book	0.95x	Market cap / tangible book value, when positive.
P/OCF	14.1x	Market cap / cash from operations, when positive.
EV/Sales	0.73x	Enterprise value / revenue.
EV/EBITDA	15.1x	Enterprise value / EBITDA, when both are positive.
Earnings yield	-5.9%	Net income / market cap (the inverse of P/E).
Dividend yield	1.2%	Dividends paid over the period / market cap.
Shareholder yield	1.2%	(Dividends paid + share buybacks) / market cap.

What was PEABODY ENERGY CORP's revenue in fiscal 2025?

PEABODY ENERGY CORP reported revenue of $3.86B for fiscal 2025, 8.9% lower than the year before.

Was PEABODY ENERGY CORP profitable in fiscal 2025?

No. It reported a net loss of $52.9M.

How much free cash flow did PEABODY ENERGY CORP generate in fiscal 2025?

Cash from operations of $333.7M minus capital expenditures of $411.4M left free cash flow of -$77.7M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to PEABODY ENERGY CORP